Somatostatin receptor (SSTR) imaging is widely used for guiding the management of
neuroendocrine tumor (NET) patients. Ga-DOTATATE approval by the US Food and Drug …

… Somatostatin receptors (SSTRs) are variably expressed by a variety of malignancies. Using
radiolabeled somatostatin … imaging and for peptide receptor radionuclide therapy. In-DTPA-…

… At time of SSTR-directed PET/CT, calcitonin was median 1400 pg/ml (range, 26–42700) …
Upon referral by the treating physician, all patients underwent SSTR-directed PET/CT due to …

… Our results further support the concept of somatostatin receptor directed PET imaging as
a readout of macrophage infiltration within areas of inflamed and/or damaged myocardium. …

… of all sites are often treated with liver-directed therapy (eg, ablation, bland … receptor
radionuclide therapy (PRRT) in well-differentiated NETs arising in the midgut, the use of SSTR PET …

… impact included directing patients to curative surgery by identifying a primary tumor site
and directing patients with multiple metastases to systemic therapy. GaTate PET/CT provided …

… Somatostatin receptor–directed PET/CT was performed because of suspected tumor
progression potentially requiring a change in therapy or to determine a rationale for PRRT. …

… rate compared with conventional somatostatin receptor scintigraphy and diagnostic CT with
… PET scan is an excellent method for screening of tumor lesions followed by a more directed …

… Five somatostatin receptor (SSTR) subtypes have been identified for TC, with conflicting
results concerning SSTR subtype frequency and expression on thyroid tumour cells, most likely …

… analogues also are being investigated for somatostatin receptor-directed radiotherapy treatment
… Similar to PETs, 85–100% of carcinoid tumours possess somatostatin sst 2 and/or sst 5 …